1.Teli, MR, James, OF, Burt, AD, Bennett, MK and Day, CP (1995) The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 22, 1714–1719.
2.Marrero, J, Fontana, RJ, Su, GL, Conjeevaram, HS, Emick, DM and Lok, AS (2002) NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 36, 1349–1354.
3.Powell, EE, Cooksley, WG, Hanson, R, Searle, J, Halliday, JW and Powell, LW (1990) The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11, 74–80.
4.Younossi, ZM, Koenig, AB, Abdelatif, D, Fazel, Y, Henry, L and Wymer, M (2016) Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73–84.
5.Ioannou, GN, Boyko, EJ and Lee, SP (2006) The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999–2002. American Journal of Gastroenterology 101, 76–82.
6.Younossi, ZM, Stepanova, M, Negro, F, Hallaji, S, Younossi, Y, Lam, B, et al. (2012) Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore) 91, 319–327.
7.Browning, JD, Szczepaniak, LS, Dobbins, R, Nuremberg, P, Horton, JD, Cohen, JC, Grundy, SM and Hobbs, HH, (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387–1395.
8.Neuschwander-Tetri, BA (2017) Non-alcoholic fatty liver disease. BMC Medicine 15, 45.
9.Almobarak, AO, Barakat, S, Khalifa, MH, Elhoweris, MH, Elhassan, TM and Ahmed, MH (2014) Non alcoholic fatty liver disease (NAFLD) in a Sudanese population: what is the prevalence and risk factors? Arab Journal of Gastroenterology 15, 12–15.
10.Onyekwere, CA, Ogbera, AO and Balogun, BO (2011) Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community. Annals of Hepatology 10, 119–124.
11.Angulo, P (2002) Nonalcoholic fatty liver disease. New England Journal of Medicine 346, 1221–1231.
12.Amiri Dash Atan, N, Koushki, M, Motedayen, M, Dousti, M, Sayehmiri, F, Vafaee, R, Norouzinia, M and Gholami, R (2017) Type 2 diabetes mellitus and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Gastroenterology and Hepatology from Bed to Bench 10(Suppl. 1), S1–S7.
13.Olusanya, TO, Lesi, OA, Adeyomoye, AA and Fasanmade, OA (2016) Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus. Pan African Medical Journal 24, 1–9.
14.Afolabi, BI, Ibitoye, BO, Ikem, RT, Omisore, AD, Idowu, BM and Soyoye, DO (2018) The relationship between glycaemic control and Non-alcoholic fatty liver disease in Nigerian type 2 diabetic patients. Journal of the National Medical Association 110, 256–264.
15.Almobarak, AO, Barakat, S, Suliman, EA, Elmadhoun, WM, Mohamed, NA, Abobaker, IO, Noor, SK, Bushara, SO and Ahmed, MH (2015) Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: is metabolic syndrome the culprit? Arab Journal of Gastroenterology 16, 54–58.
16.Zawdie, B, Tadesse, S, Wolide, AD, Nigatu, TA and Bobasa, EM (2018) Non-Alcoholic fatty liver disease and associated factors among type 2 diabetic patients in Southwest Ethiopia. Ethiopian Journal of Health Sciences 28, 19–30.
17.Paruk, IM, Pirie, FJ, Motala, AA and Kolawole, BA (2011) High prevalence of abnormal liver enzymes in South African patients with type 2 diabetes mellitus attending a diabetes clinic. Journal of Endocrinology, Metabolism and Diabetes of South Africa 16, 43–47.
18.Marchesini, G, Brizi, M, Bianchi, G, Tomassetti, S, Bugianesi, E, Lenzi, M, Noor, SK, Bushara, SO and Ahmed, MH (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50, 1844–1850.
19.Ryan, MC, Wilson, AM, Slavin, J, Best, JD, Jenkins, AJ and Desmond, PV (2005) Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease. Diabetes Care 28, 1222–1224.
20.Pang, Q, Zhang, J-Y, Song, S-D, Qu, K, Xu, X-S, Liu, S-S and Chang, L (2015) Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. World Journal of Gastroenterology 21, 1650–1662.
21.Kruger, F, Daniels, C and Kidd, M (2010) Non-alcoholic fatty liver disease (NAFLD) in the Western cape: a descriptive analysis. South African Medical Journal 100, 168–171.
22.Caldwell, SH, Harris, DM, Patrie, JT and Hespenheide, EE (2002) Is NASH underdiagnosed among African Americans? American Journal of Gastroenterology 97, 1496–1500.
23.Naran, NH, Haagensen, M and Crowther, NJ (2018) Steatosis in South African women: how much and why? PLoS One 13, 1–12.
24.Frayn, K (2002) Adipose tissue as a buffer for daily lipid flux. Diabetologia 45, 1201–1210.
25.Romeo, S, Kozlitina, J, Xing, C, Pertsemlidis, A, Cox, D, Pennacchio, LA, Boerwinkle, E, Cohen, JC and Hobbs, HH (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nature Genetics 40, 1461–1465.
26.Maurice, JB, Patel, A, Scott, AJ, Patel, K, Thursz, M and Lemoine, M (2017) Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection. AIDS (London, England) 31, 1621–1632.
27.Hoffmann, CJ, Hoffmann, JD, Kensler, C, Van Watt, MD, Omar, T, Chaisson, RE, Martinson, NA and Variava, E (2015) Tuberculosis and hepatic steatosis are prevalent liver pathology findings among HIV-infected patients in South Africa. PLoS One 10, 1–8.
28.Lesi, OA, Soyebi, KS and Eboh, CN (2009) Fatty liver and hyperlipidemia in a cohort of HIV-positive Africans on highly active antiretroviral therapy. Journal of the National Medical Association 101, 151–155.
29.Pustil, R. (2016) Global AIDS. AIDS (London, England) 17(Suppl. 4), S3–S11.
31.Bohte, AE, van Werven, JR, Bipat, S and Stoker, J (2011) The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. European Radiology 21, 87–97.
32.Tapper, EB and Loomba, R (2018) Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD. Nature Reviews. Gastroenterology & Hepatology 15, 274–282.
33.Wilman, HR, Kelly, M, Garratt, S, Matthews, PM, Milanesi, M, Herlihy, A, Gyngell, M, Neubauer, S, Bell, JD, Banerjee, R and Thomas, EL (2017) Characterisation of liver fat in the UK Biobank cohort. PLOS ONE 12, e017686.